People · Operator
Named in public records as an officer, director or promoter · active 2003–2023 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NanoVibronix, Inc. | — | Biotechnology | Series A | $31.9M | $106.4M | 2003 |
| Oramed Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $14.7M | $38.0M | 2010 |
Harold Jacob at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Harold Jacob on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Murphy | 1 | 15 |
| STEPHEN BROWN | 1 | 8 |
| James Cardwell | 1 | 4 |
| Ira Greenstein | 1 | 3 |
| William Stern | 1 | 2 |
| Paul Packer | 1 | 2 |
| Thomas R Mika | 1 | 2 |
| Thomas Mika | 1 | 2 |
| Gerald M. Ostrov | 1 | 2 |
| Leonard Sank | 1 | 1 |
| Mika R. Thomas | 1 | 1 |
| Sim Fass | 1 | 1 |
| Jona Zumeris | 1 | 1 |
| Miriam Kidron | 1 | 1 |
| Martin Goldstein | 1 | 1 |
| Martin R Goldstein | 1 | 1 |
| Michael Ferguson | 1 | 1 |
| Michael Berelowitz | 1 | 1 |
| Yifat Hen Zommer | 1 | 1 |
| Joshua Hen Hexter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.